Found: 36
Select item for more details and to access through your institution.
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Letters to the editor. The National Hemophilia Foundation provides a model of a national blood monitoring system.
- Published in:
- 1996
- By:
- Publication type:
- Journal Article
The National Hemophilia Foundation provides a model of a national blood monitoring system.
- Published in:
- 1996
- By:
- Publication type:
- commentary
Hemophilia: continued challenges but reason for optimism on many fronts.
- Published in:
- 1993
- By:
- Publication type:
- editorial
The incidence of development of irregular red cell antibodies in patients with sickle cell anemia.
- Published in:
- Transfusion, 1986, v. 26, n. 3, p. 249, doi. 10.1046/j.1537-2995.1986.26386209381.x
- By:
- Publication type:
- Article
Anti-s Hemolytic Disease: A Case Report.
- Published in:
- Transfusion, 1966, v. 6, n. 6, p. 590, doi. 10.1111/j.1537-2995.1966.tb04784.x
- By:
- Publication type:
- Article
The effect of flow confinement on laminar shock-wave/boundary-layer interactions.
- Published in:
- Journal of Fluid Mechanics, 2020, v. 897, p. 1, doi. 10.1017/jfm.2020.354
- By:
- Publication type:
- Article
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System.
- Published in:
- Haemophilia, 2017, v. 23, n. 2, p. 207, doi. 10.1111/hae.13081
- By:
- Publication type:
- Article
Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype.
- Published in:
- Haemophilia, 2015, v. 21, n. 1, p. 124, doi. 10.1111/hae.12481
- By:
- Publication type:
- Article
Therapeutic and prophylactic ethanol lock therapy in patients with bleeding disorders.
- Published in:
- Haemophilia, 2014, v. 20, n. 1, p. 52, doi. 10.1111/hae.12241
- By:
- Publication type:
- Article
Development and introduction of recombinant factor VIII - a clinician's experience.
- Published in:
- Haemophilia, 2012, v. 18, n. 4, p. 483, doi. 10.1111/j.1365-2516.2012.02804.x
- By:
- Publication type:
- Article
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII.
- Published in:
- Haemophilia, 2012, v. 18, n. 2, p. 255, doi. 10.1111/j.1365-2516.2011.02612.x
- By:
- Publication type:
- Article
Standardization of thromboelastography: a report from the TEG-ROTEM working group.
- Published in:
- Haemophilia, 2011, v. 17, n. 3, p. 532, doi. 10.1111/j.1365-2516.2010.02451.x
- By:
- Publication type:
- Article
Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans?
- Published in:
- Haemophilia, 2011, v. 17, n. 3, p. 483, doi. 10.1111/j.1365-2516.2010.02429.x
- By:
- Publication type:
- Article
Prophylactic therapy with Fibrogammin<sup>®</sup> P is associated with a decreased incidence of bleeding episodes: a retrospective study.
- Published in:
- Haemophilia, 2010, v. 16, n. 2, p. 316, doi. 10.1111/j.1365-2516.2009.02123.x
- By:
- Publication type:
- Article
Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients.
- Published in:
- Haemophilia, 2009, v. 15, n. 6, p. 1267, doi. 10.1111/j.1365-2516.2009.02075.x
- By:
- Publication type:
- Article
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention’s (CDC) Universal Data Collection (UDC) project.
- Published in:
- Haemophilia, 2009, v. 15, n. 6, p. 1281, doi. 10.1111/j.1365-2516.2009.02074.x
- By:
- Publication type:
- Article
Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997–2006).
- Published in:
- Haemophilia, 2009, v. 15, n. 5, p. 1027, doi. 10.1111/j.1365-2516.2009.02039.x
- By:
- Publication type:
- Article
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII
- Published in:
- Haemophilia, 2009, v. 15, n. 4, p. 869, doi. 10.1111/j.1365-2516.2009.02027.x
- By:
- Publication type:
- Article
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: A White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA.
- Published in:
- Haemophilia, 2006, v. 12, n. 3, p. 205, doi. 10.1111/j.1365-2516.2006.01277.x
- By:
- Publication type:
- Article
The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update.
- Published in:
- 2005
- By:
- Publication type:
- Letter
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study.
- Published in:
- Haemophilia, 2005, v. 11, n. 2, p. 84, doi. 10.1111/j.1365-2516.2005.01068.x
- By:
- Publication type:
- Article
The overall effectiveness of prophylaxis in severe haemophilia.
- Published in:
- Haemophilia, 2003, v. 9, n. 3, p. 272, doi. 10.1046/j.1365-2516.2003.00757.x
- By:
- Publication type:
- Article
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2003, v. 9, n. 1, p. 38, doi. 10.1046/j.1365-2516.2003.00708.x
- By:
- Publication type:
- Article
Inhibitor development and FVIII gene mutation analysis in a pediatric cohort treated with sucrose formulated, full-length recombinant Factor VIII.
- Published in:
- Haemophilia, 2002, v. 8, n. 6, p. 836, doi. 10.1046/j.1365-2516.2002.d01-2_4.x
- By:
- Publication type:
- Article
In vivo recovery with products of very high purity — assay discrepancies.
- Published in:
- Haemophilia, 1998, v. 4, n. 4, p. 641, doi. 10.1046/j.1365-2516.1998.440641.x
- By:
- Publication type:
- Article
Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures.
- Published in:
- Haemophilia, 1997, v. 3, n. 4, p. 247, doi. 10.1046/j.1365-2516.1997.00110.x
- By:
- Publication type:
- Article
Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience.
- Published in:
- Haemophilia, 1997, v. 3, n. 3, p. 194, doi. 10.1046/j.1365-2516.1997.00117.x
- By:
- Publication type:
- Article
Factor IX inhibitors and anaphylaxis in haemophilia B.
- Published in:
- Haemophilia, 1996, v. 2, n. 4, p. 259, doi. 10.1111/j.1365-2516.1996.tb00149.x
- By:
- Publication type:
- Article
Types of bleeding seen during the first 30 months of life in children with severe haemophilia A and B.
- Published in:
- Haemophilia, 1996, v. 2, n. 3, p. 137, doi. 10.1111/j.1365-2516.1996.tb00156.x
- By:
- Publication type:
- Article
Org 214007-0: A Novel Non-Steroidal Selective Glucocorticoid Receptor Modulator with Full Anti-Inflammatory Properties and Improved Therapeutic Index.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048385
- By:
- Publication type:
- Article
Protocols, Dosages and Clinical Aspects of Immune Tolerance.
- Published in:
- Vox Sanguinis, 1996, v. 70, p. 60, doi. 10.1111/j.1423-0410.1996.tb01351.x
- By:
- Publication type:
- Article
Transmission of Human Immunodeficiency Virus Type 1 by Dry-Heated Clotting Factor Concentrates.
- Published in:
- Vox Sanguinis, 1990, v. 59, n. 3, p. 129, doi. 10.1111/j.1423-0410.1990.tb00846.x
- By:
- Publication type:
- Article
IMFRA (Intermittent Intrathecal Methotrexate and Fractional Radiation) plus chemotherapy in childhood leukemia.
- Published in:
- American Journal of Hematology, 1976, v. 1, n. 2, p. 191, doi. 10.1002/ajh.2830010203
- By:
- Publication type:
- Article
On the performance of WENO/TENO schemes to resolve turbulence in DNS/LES of high‐speed compressible flows.
- Published in:
- International Journal for Numerical Methods in Fluids, 2021, v. 93, n. 1, p. 176, doi. 10.1002/fld.4879
- By:
- Publication type:
- Article